Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-043151
Filing Date
2017-08-14
Accepted
2017-08-14 16:12:24
Documents
3
Period of Report
2017-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v473262_6k.htm 6-K 11273
2 EXHIBIT 99.1 v473262_ex99-1.htm EX-99.1 32218
3 GRAPHIC bbp_logo.jpg GRAPHIC 7365
  Complete submission text file 0001144204-17-043151.txt   54909
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 171030217
SIC: 2834 Pharmaceutical Preparations